Review articlePublished 30 Dec 2020
Chloroquine and Hydroxychloroquine: A Closer Look on Skeletal Muscle
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Chloroquine (CQ) and Hydroxychloroquine (HCQ), antimalarial agents and widely used in the treatment of autoimmune diseases are considered safe nonetheless, they can provoke side effects, including myopathy. Literature data regarding the prevalence and incidence of this toxic myopathy are scarce and main symptoms encompass Proximal Muscle Weakness (PMW) and normal or slightly elevated creatine kinase (CK) levels. So, definitive diagnosis requires muscle biopsy, showing autophagic vacuoles and curvilinear bodies. The results from a literature review, revealed PMW in 87.2% and respiratory distress in 12.5% of patients; dysphagia, cervical and axial weakness in 8.9%, 17.8%, and 1.8%, respectively. Elevated CK levels in 60.7%, EMG with myopathic pattern in 54% and vacuolar myopathy in 53.7% associated to “curvilinear bodies” in 86.8%. The recovery after discontinuation of therapy occurred in 85.4%. Clinicians should be aware about this possible condition. Even with normal CK levels, muscle biopsy must be the gold-standard tool to diagnose and differentiate patients with this condition from other neuromuscular disorders.
Subjects
RheumatologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalLupus: Open Access
- SubjectRheumatology
- BylineArticles whose byline prints “Alzira Alves de Siqueira Carvalho”
